United Therapeutics buy UBS Group AG
Start price
08.01.25
/
50%
€355.30
Target price
08.01.26
€460.94
Performance (%)
18.44%
Price
18:23
€420.80
Summary
This prediction is currently active. The prediction currently has a performance of 18.44%. This prediction currently runs until 08.01.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 1.226% | 1.226% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at UBS Group AG from $415.00 to $475.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€393.20
06.11.25
06.11.25
€521.34
06.11.26
06.11.26
7.02%
18:23
18:23
United Therapeutics
Start price
Target price
Perf. (%)
€360.40
29.09.25
29.09.25
€494.80
29.09.26
29.09.26
16.76%
18:23
18:23
United Therapeutics
Start price
Target price
Perf. (%)
€337.60
04.09.25
04.09.25
€480.20
04.09.26
04.09.26
24.64%
18:23
18:23
United Therapeutics
Start price
Target price
Perf. (%)
€258.80
13.08.25
13.08.25
€355.41
13.08.26
13.08.26
62.60%
18:23
18:23
United Therapeutics
Start price
Target price
Perf. (%)
€244.10
30.06.25
30.06.25
€328.48
30.06.26
30.06.26
72.39%
18:23
18:23
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-14.82%
09.07.25
09.07.25